Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
AN-1792 AIP 001 Discontinued Janssen, Pfizer APP and Amyloid-Related Immunotherapy (active) Alzheimer's Disease None
Avagacestat BMS-708163 Discontinued Bristol-Myers Squibb APP and Amyloid-Related Small Molecule Alzheimer's Disease
Bapineuzumab AAB-001 Discontinued Janssen, Pfizer APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
E2609 BACE1 inhibitor 1, Discontinued Eisai Co., Ltd. APP and Amyloid-Related Small Molecule Alzheimer's Disease, Mild Cognitive Impairment
Flurizan™ tarenflurbil , r-flurbiprofen, MPC-7869 Discontinued Myriad Genetics & Laboratories APP and Amyloid-Related Small Molecule Alzheimer's Disease None
Gammagard™ Intravenous Immunoglobulin, IVIg Discontinued Baxter Healthcare APP and Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease Immunodeficiency conditions
LY2886721 β-secretase inhibitor Discontinued, Discontinued Eli Lilly & Co. APP and Amyloid-Related Small Molecule Alzheimer's Disease, Mild Cognitive Impairment
Ponezumab PF-04360365 Discontinued, 2 Pfizer APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease, Cerebral Amyloid Angiopathy None
RG7129 RO5508887, BACE1 Inhibitor Discontinued Roche Products (Ireland) Limited APP and Amyloid-Related Small Molecule Alzheimer's Disease
Semagacestat LY450139 Dihydrate , hydroxylvaleryl monobenzocaprolactam Discontinued Eli Lilly & Co. APP and Amyloid-Related Small Molecule Alzheimer's Disease None
Vanutide cridificar ACC-001, PF-05236806 Discontinued Pfizer APP and Amyloid-Related Immunotherapy (active) Alzheimer's Disease None